IVD and Lab Consolidation Reduces Choices for Labs

By Robert Michel | From the Volume XXX, No. 13 – September 11, 2023 Issue

CEO SUMMARY: Since the launch of The Dark Report in 1995, consolidation of hospitals, physician groups, clinical labs, pathology groups, and IVD manufacturers has been a major trend every year. Toda…

Read More

---

Digital Pathology Sales Put Gestalt on Inc. 5000’s Fast Growth List

By Scott Wallask | From the Volume XXX, No. 12 – August 21, 2023 Issue

Digital pathology workflow provider Gestalt Diagnostics earned a place on the Inc. 5000 2023 list of the fastest growing p…

Read More

---

Labcorp: Ascension Deal Will Earn $550 Million in 2023

By Robert Michel | From the Volume XXX No. 4 – March 6, 2023 Issue

PUBLICLY TRADED LABORATORY COMPANIES OFFERED INSIGHTS into how acquisitions of hospital lab operations and outreach businesses add to their bottom lines, according to recent reports on full-year 2022 and fourth quarter earnings.  Last year was a busy one…

Read More

---

March 6, 2023, Intelligence: Late-Breaking Lab News

By Scott Wallask | From the Volume XXX No. 4 – March 6, 2023 Issue

Since Congress did not include new regulations for laboratory-developed tests (LDTs) in a year-end spending budget, it appears the Food and Drug Administration (FDA) will take steps of its own to increase the agency’s oversight of LDTs. “We are moving forward with rulemaking,” said Eliza…

Read More

---

Telemedicine Firms Offer Home Phlebotomy Service

By Scott Wallask | From the Volume XXIX, No. 13 – September 19, 2022 Issue

CEO SUMMARY: Telemedicine provider Teladoc Health has announced new services for certain primary care customers that include at-home phlebotomy appointments. The move is evidence of the consumer demand for increased convenience and flexibility in their healthcare. Scarlet Health, a …

Read More

---

Public Laboratory Companies Eye More Lab Outreach Acquisitions

By Robert Michel | From the Volume XXIX, No. 12 – August 29, 2022 Issue

PUBLICLY-TRADED CLINICAL LABORATORY COMPANIES released second quarter 2022 financial reports that confirmed a softening demand for COVID-19 tests, even as their base business revenues grew compared to last year.  While continuing to address ongoing needs…

Read More

---

August 29, 2022 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXIX, No. 12 – August 29, 2022 Issue

Interesting things may be unfolding in the genetic testing marketplace. In the past few weeks, at least two high-profile genetic testing companies announced major layoffs. First was Invitae, a genetics testing company in San Francisco. At the end of July, it announced plans to eliminate 1,000 …

Read More

---

October 18, 2021 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXVIII, No. 14 – October 18, 2021 Issue

One interesting development from the SARS-CoV-2 outbreak is a new ability to collect genetic data on the virus and its variants from a growing number of countries across the globe. The World reported that “In March, the one millionth genomic sequence for the new coronavirus came from Chile; …

Read More

---

India’s Neuberg Diagnostics Expands into U.S. Market

By Robert Michel | From the Volume XXVIII, No. 11 – August 16, 2021 Issue

“Our idea is to enhance the access and affordability for next-generation techniques, meaning molecular diagnostics, genomics, pathology, digital pathology, proteomics, metabolomics, and all that. This is the spirit behind Neuberg Diagnostics. —GSK Velu, PhD, BPharm …

Read More

---

Goodbye Clinical Labs! Hello Genetic Testing Labs!

By R. Lewis Dark | From the Volume XXVIII, No. 10 – July 26, 2021 Issue

IS THE CLASSIC MODEL OF THE INDEPENDENT PATHOLOGIST-OWNED CLINICAL LABORATORY that is the sole source provider of all routine, reference, and esoteric testing to physicians in its community on its way to extinction? There is strong evidence to support a “yes” answer to that question….

Read More

---